Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Receptor-type tyrosine-protein phosphatase κ directly targets STAT3 activation for tumor suppression in nasal NK/T-cell lymphoma

Yun-Wen Chen, Tianhuan Guo, Lijun Shen, Kai-Yau Wong, Qian Tao, William W. L. Choi, Rex K. H. Au-Yeung, Yuen-Piu Chan, Michelle L. Y. Wong, Johnny C. O. Tang, Wei-Ping Liu, Gan-Di Li, Norio Shimizu, Florence Loong, Eric Tse, Yok-Lam Kwong, Gopesh Srivastava

Blood (2015) 125 (10): 1589–1600.

https://doi.org/10.1182/blood-2014-07-588970

Published: 2015

Includes: Supplemental data

Journal Articles

Epigenetic Silencing of the Receptor Tyrosine Phosphatase, PTPRK , Located At the Frequently Deleted 6q22.33-q23.2 Region, Leads to Tumor Growth Via the Constitutive Activation of STAT3 in Nasal-Type NK/T-Cell Lymphoma

Yun-Wen Chen, Tianhuan Guo, Lijun Shen, Kai-Yau Wong, Wing-Yan Au, MD, Qian Tao, Lok-Yi Wong, Cheuk-On Tang, Wai Lap Choi, Wei-Ping Liu, Gan-Di Li, Norio Shimizu, Junjiro Tsuchiyama, Florence Loong, Raymond Liang, MD, FRCP, Yok Lam Kwong, MD, Gopesh Srivastava, Ph.D

Blood (2011) 118 (21): 1378.

https://doi.org/10.1182/blood.V118.21.1378.1378

Published: 2011

Journal Articles

CD44 activation in mature B-cell malignancies by a novel recurrent IGH translocation

Blood (2010) 115 (12): 2458–2461.

https://doi.org/10.1182/blood-2009-09-238782

Published: 2010

Includes: Supplemental data

Journal Articles

WNT5A is epigenetically silenced in hematologic malignancies and inhibits leukemia cell growth as a tumor suppressor

Jianming Ying, Hongyu Li, Yun-Wen Chen, Gopesh Srivastava, Zifen Gao, Qian Tao

Blood (2007) 110 (12): 4130–4131.

https://doi.org/10.1182/blood-2007-06-094870

Published: 2007

Journal Articles

High BCL6 expression predicts better prognosis, independent of BCL6 translocation status, translocation partner, or BCL6 -deregulating mutations, in gastric lymphoma

Yun-Wen Chen, Xiao-Tong Hu, Anthony C. Liang, Wing-Yan Au, Chi-Chiu So, Michelle L. Wong, Lijun Shen, Qian Tao, Kent-Man Chu, Yok-Lam Kwong, Raymond H. Liang, Gopesh Srivastava

Blood (2006) 108 (7): 2373–2383.

https://doi.org/10.1182/blood-2006-05-022517

Published: 2006

Includes: Supplemental data

Journal Articles

Promoter hypermethylation of the cyclin-dependent kinase inhibitor (CDKI) gene p21 WAF1/CIP1/SDI1 is rare in various lymphomas and carcinomas

Jianming Ying, Gopesh Srivastava, Zifen Gao, Xiaohua Zhang, Paul Murray, Richard Ambinder, Qian Tao

Blood (2004) 103 (2): 743–746.

https://doi.org/10.1182/blood-2003-09-3193

Published: 2004

Journal Articles

Characterization of Epstein-Barr virus–infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response

Jie Yang, Qian Tao, Ian W. Flinn, Paul G. Murray, Linda E. Post, Hong Ma, Steven Piantadosi, Michael A. Caligiuri, Richard F. Ambinder

Blood (2000) 96 (13): 4055–4063.

https://doi.org/10.1182/blood.V96.13.4055

Published: 2000

Journal Articles

Coinfection of multiple strains of Epstein-Barr virus in immunocompetent normal individuals: reassessment of the viral carrier state

Gopesh Srivastava, Kai Y. Wong, Alan K. S. Chiang, King Y. Lam, Qian Tao

Blood (2000) 95 (7): 2443–2445.

https://doi.org/10.1182/blood.V95.7.2443

Published: 2000

Journal Articles

Epstein-Barr Virus (EBV) in Endemic Burkitt's Lymphoma: Molecular Analysis of Primary Tumor Tissue

Qian Tao, Keith D. Robertson, Angela Manns, Allan Hildesheim, Richard F. Ambinder

Blood (1998) 91 (4): 1373–1381.

https://doi.org/10.1182/blood.V91.4.1373

Published: 1998

Journal Articles

Epstein-Barr Virus Lytic Infection in Lymphocytes and the Persistence of the Virus

Qian Tao

Blood (1997) 90 (5): 2114–2116.

https://doi.org/10.1182/blood.V90.5.2114b

Published: 1997

NARROW

Receptor-type tyrosine-protein phosphatase κ directly targets STAT3 activation for tumor suppression in nasal NK/T-cell lymphoma

Epigenetic Silencing of the Receptor Tyrosine Phosphatase, PTPRK , Located At the Frequently Deleted 6q22.33-q23.2 Region, Leads to Tumor Growth Via the Constitutive Activation of STAT3 in Nasal-Type NK/T-Cell Lymphoma

CD44 activation in mature B-cell malignancies by a novel recurrent IGH translocation

WNT5A is epigenetically silenced in hematologic malignancies and inhibits leukemia cell growth as a tumor suppressor

High BCL6 expression predicts better prognosis, independent of BCL6 translocation status, translocation partner, or BCL6 -deregulating mutations, in gastric lymphoma

Promoter hypermethylation of the cyclin-dependent kinase inhibitor (CDKI) gene p21 WAF1/CIP1/SDI1 is rare in various lymphomas and carcinomas

Characterization of Epstein-Barr virus–infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response

Coinfection of multiple strains of Epstein-Barr virus in immunocompetent normal individuals: reassessment of the viral carrier state

Epstein-Barr Virus (EBV) in Endemic Burkitt's Lymphoma: Molecular Analysis of Primary Tumor Tissue

Epstein-Barr Virus Lytic Infection in Lymphocytes and the Persistence of the Virus

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only